Dong Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dong Chen has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Jianfeng Shang
Capital Med Univ, Beijing Anzhen Hosp, Dept Pathol, 2 Anzhen Rd, Beijing 100029, Peoples R China
6 shared publicationsWei Fang
Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China
4 shared publicationsJiaqi Wang
Capital Medical University
3 shared publicationsFang Dong
Capital Med Univ, Beijing Anzhen Hosp, Dept Pathol, 2 Anzhen Rd, Beijing 100029, Peoples R China
2 shared publications- Fei Teng
Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2 shared publications Guoliang Lian
Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2 shared publications
Latest Publications
- 22 October 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
The Largest Cohort Study of Intravenous Leiomyomatosis Reveals HMGA2 and Collagen Gene Alterations as Cooperative Drivers
Intravenous leiomyomatosis (IVL) is a rare, hormonally responsive smooth muscle neoplasm defined by nondestructive intravascular growth. Despite its distinct clinical behavior, the comprehensive molecular landscape of IVL has not been systematically characterized. We collected the clinicopathologic characteristics of 89 IVLs, 106 conventional uterine leiomyomas (cULMs), and 83 cellular leiomyomas (CLs). Using immunohistochemistry (IHC), we evaluated high mobility group AT-hook 2 (HMGA2) expression in 88 IVLs, 106 cULMs, and 83 CLs. We also assessed fumarate hydratase (FH) and 2-succinocysteine status by IHC in 82 IVLs. Fluorescence in situ hybridization was performed using the HMGA2 break-apart probe in 84 IVLs and the HMGA2/RAD51B fusion probe in 83 IVLs. We detected MED12 exon 2 hotspot mutations by Sanger sequencing in 79 IVLs. Whole-exome sequencing (WES) was performed in 10 IVLs. We found that IVL predominantly affected reproductive-aged women, most with a history of uterine trauma. HMGA2 expression was upregulated in 87.5% (77/88) of IVLs, with strong immunoreactivity in 40.9% (36/88) of IVLs. Half of IVLs harbored HMGA2 rearrangements, predominantly the HMGA2/RAD51B fusion. WES revealed frequent mutations in collagen (COL) gene family members (70.0%, 7/10), all co-occurring with HMGA2 upregulation. Conversely, MED12 exon 2 mutations (2.5%, 2/79) and FH deficiency (2.4%, 2/82) were rare events in this cohort. We propose that IVL pathogenesis likely involves synergistic interplay between dysregulated HMGA2 and COL gene family alterations within a permissive microenvironment influenced by hormones and uterine trauma. FH deficiency and MED12 exon 2 hotspot mutations appear infrequent in IVL and may not represent primary drivers of disease initiation.
- 22 October 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
The Largest Cohort Study of Intravenous Leiomyomatosis Reveals HMGA2 and Collagen Gene Alterations as Cooperative Drivers
Intravenous leiomyomatosis (IVL) is a rare, hormonally responsive smooth muscle neoplasm defined by nondestructive intravascular growth. Despite its distinct clinical behavior, the comprehensive molecular landscape of IVL has not been systematically characterized. We collected the clinicopathologic characteristics of 89 IVLs, 106 conventional uterine leiomyomas (cULMs), and 83 cellular leiomyomas (CLs). Using immunohistochemistry (IHC), we evaluated high mobility group AT-hook 2 (HMGA2) expression in 88 IVLs, 106 cULMs, and 83 CLs. We also assessed fumarate hydratase (FH) and 2-succinocysteine status by IHC in 82 IVLs. Fluorescence in situ hybridization was performed using the HMGA2 break-apart probe in 84 IVLs and the HMGA2/RAD51B fusion probe in 83 IVLs. We detected MED12 exon 2 hotspot mutations by Sanger sequencing in 79 IVLs. Whole-exome sequencing (WES) was performed in 10 IVLs. We found that IVL predominantly affected reproductive-aged women, most with a history of uterine trauma. HMGA2 expression was upregulated in 87.5% (77/88) of IVLs, with strong immunoreactivity in 40.9% (36/88) of IVLs. Half of IVLs harbored HMGA2 rearrangements, predominantly the HMGA2/RAD51B fusion. WES revealed frequent mutations in collagen (COL) gene family members (70.0%, 7/10), all co-occurring with HMGA2 upregulation. Conversely, MED12 exon 2 mutations (2.5%, 2/79) and FH deficiency (2.4%, 2/82) were rare events in this cohort. We propose that IVL pathogenesis likely involves synergistic interplay between dysregulated HMGA2 and COL gene family alterations within a permissive microenvironment influenced by hormones and uterine trauma. FH deficiency and MED12 exon 2 hotspot mutations appear infrequent in IVL and may not represent primary drivers of disease initiation.
- Open Access
- 8 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 162
A Diagnostic Dilemma of Arrhythmogenic Cardiomyopathy Masquerading as Recurrent Myocarditis in a Pediatric Patient with a DES Gene Variant: A Case Report
Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited disorder characterized by fibrofatty replacement of cardiomyocytes. The inflammatory episodes of ACM, known as the “hot phase”, can mimic acute myocarditis. It was seldom observed in a DES-associated ACM as a “hot-phase” presentation. Case Presentation: The proband, a 13-year-old female, initially presented with a series of clinical manifestations of fulminant myocarditis. Although recommendation-guided anti-immunotherapy had been provided, this patient still developed into an aggressive cardiomyopathy with biventricular dilation and severe systolic heart failure. Additionally, cardiac magnetic resonance demonstrated circumferential late gadolinium enhancement in left ventricular myocardium with diffuse fibrosis. Whole-exon sequencing identified a de novo missense variant, as c.335T>A (p.L112Q) of the DES gene, resulting in protein dysfunction. And a diagnosis of ACM due to a DES variant had been identified. Finally, this patient received heart transplantation, and biventricular fibrofatty infiltration was confirmed by pathological analysis. Conclusions: This case presented a de novo genetic variant that can induce severe and aggressive heart failure. This finding emphasizes the importance of comprehensive genetic analysis in patients suspected of having fulminant myocarditis, which would greatly benefit the precise clinical management and outcomes.
- 8 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 162
Open AccessA Diagnostic Dilemma of Arrhythmogenic Cardiomyopathy Masquerading as Recurrent Myocarditis in a Pediatric Patient with a DES Gene Variant: A Case Report
Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited disorder characterized by fibrofatty replacement of cardiomyocytes. The inflammatory episodes of ACM, known as the “hot phase”, can mimic acute myocarditis. It was seldom observed in a DES-associated ACM as a “hot-phase” presentation. Case Presentation: The proband, a 13-year-old female, initially presented with a series of clinical manifestations of fulminant myocarditis. Although recommendation-guided anti-immunotherapy had been provided, this patient still developed into an aggressive cardiomyopathy with biventricular dilation and severe systolic heart failure. Additionally, cardiac magnetic resonance demonstrated circumferential late gadolinium enhancement in left ventricular myocardium with diffuse fibrosis. Whole-exon sequencing identified a de novo missense variant, as c.335T>A (p.L112Q) of the DES gene, resulting in protein dysfunction. And a diagnosis of ACM due to a DES variant had been identified. Finally, this patient received heart transplantation, and biventricular fibrofatty infiltration was confirmed by pathological analysis. Conclusions: This case presented a de novo genetic variant that can induce severe and aggressive heart failure. This finding emphasizes the importance of comprehensive genetic analysis in patients suspected of having fulminant myocarditis, which would greatly benefit the precise clinical management and outcomes.
- Open Access
- 5 February 2026
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 33, e00226060
Intrapericardial cavernous hemangioma: a rare cause of persistent dyspnea and a diagnostic challenge
- 5 February 2026
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 33, e00226060
Open AccessIntrapericardial cavernous hemangioma: a rare cause of persistent dyspnea and a diagnostic challenge
- Open Access
- 3 February 2026
- Published by Springer Nature in Research Square
Protonation-Guided Design and Evaluation of Selective PET Tracers for Light Chain Cardiac Amyloidosis
Early detection of cardiac amyloidosis (CA) is challenging, despite advances in repurposed β -amyloid PET tracers and amyloid-targeted [ 124 I]Evuzamitide. The heterogeneity of CA subtypes requires invasive tests, like tissue biopsy, before targeted therapy can begin. Amyloidogenic light chains (AL) expose negatively charged pockets enriched in acidic residues and N-glycosylated modifications, guiding the design of selective molecular probes. We showed that protonation-driven recognition accomplishes unprecedented selectivity for AL deposits. Using this principle, we developed a fluorinated derivative, [ 18 F] FT-8 , based on a 4-pyridylpiperazine scaffold, which displayed high binding affinity ( K i = 11.52 nM) and selectivity towards AL, as well as favorable pharmacokinetics. In first-in-human PET studies, [ 18 F] FT-8 provided high-contrast visualization of AL deposits in the myocardium and extracardiac organs with significant specificity. These findings position [ 18 F] FT-8 as a promising PET tracer for advancing the non-invasive differential diagnosis of AL-CA and highlighting the role of protonation in developing new-generation molecular probes across diverse disease contexts.
- 3 February 2026
- Published by Springer Nature in Research Square
Open AccessProtonation-Guided Design and Evaluation of Selective PET Tracers for Light Chain Cardiac Amyloidosis
Early detection of cardiac amyloidosis (CA) is challenging, despite advances in repurposed β -amyloid PET tracers and amyloid-targeted [ 124 I]Evuzamitide. The heterogeneity of CA subtypes requires invasive tests, like tissue biopsy, before targeted therapy can begin. Amyloidogenic light chains (AL) expose negatively charged pockets enriched in acidic residues and N-glycosylated modifications, guiding the design of selective molecular probes. We showed that protonation-driven recognition accomplishes unprecedented selectivity for AL deposits. Using this principle, we developed a fluorinated derivative, [ 18 F] FT-8 , based on a 4-pyridylpiperazine scaffold, which displayed high binding affinity ( K i = 11.52 nM) and selectivity towards AL, as well as favorable pharmacokinetics. In first-in-human PET studies, [ 18 F] FT-8 provided high-contrast visualization of AL deposits in the myocardium and extracardiac organs with significant specificity. These findings position [ 18 F] FT-8 as a promising PET tracer for advancing the non-invasive differential diagnosis of AL-CA and highlighting the role of protonation in developing new-generation molecular probes across diverse disease contexts.
- 10 January 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (5) , 3364-3374
Preclinical and preliminary clinical evaluation of [18F]Florbetazine for non-invasive PET detection of cardiac amyloidosis
Purpose Early detection of cardiac amyloidosis (CA) remains challenging, and a PET tracer capable of directly visualizing amyloid deposits could improve diagnosis. Given the shared β-sheet structure of amyloid deposits in CA and Alzheimer’s disease (AD), this study aimed to evaluate the suitability of the AD amyloid tracer [18F]Florbetazine for non-invasive detection of CA via preclinical assessments and preliminary clinical evaluation. Methods Specific binding and affinity of [18F]Florbetazine to amyloid light-chain (AL) and transthyretin (ATTR) deposits were assessed via in vitro autoradiography on human myocardial sections. Pharmacokinetics and biodistribution were characterized by dynamic micro-PET/CT imaging in healthy Sprague Dawley (SD) rats. Whole-body PET/CT imaging was performed in two healthy volunteers to estimate normal-organ background, and in a single patient with biopsy-proven AL amyloidosis to preliminarily explore diagnostic feasibility. Results Autoradiography confirmed specific binding of [18F]Florbetazine to both AL and ATTR deposits with high binding affinities (Kd = 20.85 nM and 54.10 nM, respectively). In rats, [18F]Florbetazine exhibited rapid myocardial and renal uptake followed by efficient clearance from normal tissues. In healthy volunteers, background myocardium and renal activity was minimal by 40 min post-injection. In the AL amyloidosis patient, delayed-phase PET/CT imaging (60–70 min) revealed intense myocardium and renal uptake, correlating with renal biopsy findings. Conclusions These integrated preclinical and preliminary clinical evaluation demonstrates that [18F]Florbetazine binds cardiac amyloid with high affinity and displays favorable pharmacokinetics, warranting further investigation in larger, systematically designed clinical studies. Trial registration Clinical trial registry NCT06593626 (registered 24 May 2024) and NCT06725706 (registered 5 Dec 2024).
- 10 January 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (5) , 3364-3374
Preclinical and preliminary clinical evaluation of [18F]Florbetazine for non-invasive PET detection of cardiac amyloidosis
Purpose Early detection of cardiac amyloidosis (CA) remains challenging, and a PET tracer capable of directly visualizing amyloid deposits could improve diagnosis. Given the shared β-sheet structure of amyloid deposits in CA and Alzheimer’s disease (AD), this study aimed to evaluate the suitability of the AD amyloid tracer [18F]Florbetazine for non-invasive detection of CA via preclinical assessments and preliminary clinical evaluation. Methods Specific binding and affinity of [18F]Florbetazine to amyloid light-chain (AL) and transthyretin (ATTR) deposits were assessed via in vitro autoradiography on human myocardial sections. Pharmacokinetics and biodistribution were characterized by dynamic micro-PET/CT imaging in healthy Sprague Dawley (SD) rats. Whole-body PET/CT imaging was performed in two healthy volunteers to estimate normal-organ background, and in a single patient with biopsy-proven AL amyloidosis to preliminarily explore diagnostic feasibility. Results Autoradiography confirmed specific binding of [18F]Florbetazine to both AL and ATTR deposits with high binding affinities (Kd = 20.85 nM and 54.10 nM, respectively). In rats, [18F]Florbetazine exhibited rapid myocardial and renal uptake followed by efficient clearance from normal tissues. In healthy volunteers, background myocardium and renal activity was minimal by 40 min post-injection. In the AL amyloidosis patient, delayed-phase PET/CT imaging (60–70 min) revealed intense myocardium and renal uptake, correlating with renal biopsy findings. Conclusions These integrated preclinical and preliminary clinical evaluation demonstrates that [18F]Florbetazine binds cardiac amyloid with high affinity and displays favorable pharmacokinetics, warranting further investigation in larger, systematically designed clinical studies. Trial registration Clinical trial registry NCT06593626 (registered 24 May 2024) and NCT06725706 (registered 5 Dec 2024).
- Open Access
- 1 July 2024
- Published by AME Publishing Company in AME Case Reports
- Vol. 8, 59
Idiopathic cardiac ossification with Chiari mesh in the right atrium: a case report and literature review
Background: Idiopathic cardiac osseous metaplasia in the right atrium of a 9-year-old boy, accompanied by right atrial Chiari network and right pulmonary artery embolism. This case is rare and can easily be misdiagnosed. Case Description: We encountered a case of a 9-year-old boy with a 3.5 cm diameter neoplasm in the right atrium. Preoperative imaging diagnosis could not determine the nature of the tumor, and the initial clinical suspicion of cardiac myxoma. After admission, a cardiotomy to remove foreign bodies and a pulmonary artery thrombectomy were performed. Conclusions: Idiopathic cardiac osseous metaplasia is relatively rare, and it is even rarer to be accompanied by a Chiari network in the right atrium. Due to the location and characteristics of the lesion in this case, it is easy to be misdiagnosed as atrial myxoma in clinical practice. Whether it is idiopathic osseous metaplasia or myxoma, it needs to be performed surgical treatment and pathological examination can easily rule out the diagnosis of myxoma. However, as idiopathic cardiac metaplasia is difficult to encounter in clinical work and there are few reports in the literature, clinicians and pathologists need to consult more relevant literature. Learn to understand and master the disease through multi-party consultation.
- 1 July 2024
- Published by AME Publishing Company in AME Case Reports
- Vol. 8, 59
Open AccessIdiopathic cardiac ossification with Chiari mesh in the right atrium: a case report and literature review
Background: Idiopathic cardiac osseous metaplasia in the right atrium of a 9-year-old boy, accompanied by right atrial Chiari network and right pulmonary artery embolism. This case is rare and can easily be misdiagnosed. Case Description: We encountered a case of a 9-year-old boy with a 3.5 cm diameter neoplasm in the right atrium. Preoperative imaging diagnosis could not determine the nature of the tumor, and the initial clinical suspicion of cardiac myxoma. After admission, a cardiotomy to remove foreign bodies and a pulmonary artery thrombectomy were performed. Conclusions: Idiopathic cardiac osseous metaplasia is relatively rare, and it is even rarer to be accompanied by a Chiari network in the right atrium. Due to the location and characteristics of the lesion in this case, it is easy to be misdiagnosed as atrial myxoma in clinical practice. Whether it is idiopathic osseous metaplasia or myxoma, it needs to be performed surgical treatment and pathological examination can easily rule out the diagnosis of myxoma. However, as idiopathic cardiac metaplasia is difficult to encounter in clinical work and there are few reports in the literature, clinicians and pathologists need to consult more relevant literature. Learn to understand and master the disease through multi-party consultation.
- 2 January 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (6) , e164
A UFO-like cavernous haemangiomas in the atrial septum visualized by three-dimensional transoesophageal echocardiography
A 55-year-old woman presented with paroxysmal chest tightness for over a month. She has a history of hypertension and takes her regularly prescribed medication, irregularly. She had surgery for a herniated disc 9 years ago. Physical examination and laboratory tests were normal. Transthoracic echocardiography showed an equal-echo mass in the middle of the atrial septum, with a wide base, extending to the right and left atrium (Panel A). Two-dimensional transoesophageal echocardiography showed a 3.5 × 4.1 cm mass in the middle and lower atrial septum, with homogeneous echo (Panel B). Three-dimensional transoesophageal echocardiography revealed a UFO-like mass in the middle of the atrial septum, with smooth and regular surfaces and clear boundaries on the left atrial view. The mass was located immediately adjacent to the aortic non-coronary sinus and the base of the anterior leaflet of the mitral valve (Panels C and D). During surgery, a dark red circular mass in the middle of the atrial septum was visualized (Panel E). The mass in the atrial septum was resected under total cardiopulmonary bypass. The post-operative course was uneventful, and the patient was discharged in a good condition 1 week after surgery. Post-operative histopathological examination revealed endothelial cells, communicating dilated vascular channels, and clusters of red blood cells inside the vascular lumen; thus, it was diagnosed as a cavernous haemangioma (Panel F).
- 2 January 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (6) , e164
A UFO-like cavernous haemangiomas in the atrial septum visualized by three-dimensional transoesophageal echocardiography
A 55-year-old woman presented with paroxysmal chest tightness for over a month. She has a history of hypertension and takes her regularly prescribed medication, irregularly. She had surgery for a herniated disc 9 years ago. Physical examination and laboratory tests were normal. Transthoracic echocardiography showed an equal-echo mass in the middle of the atrial septum, with a wide base, extending to the right and left atrium (Panel A). Two-dimensional transoesophageal echocardiography showed a 3.5 × 4.1 cm mass in the middle and lower atrial septum, with homogeneous echo (Panel B). Three-dimensional transoesophageal echocardiography revealed a UFO-like mass in the middle of the atrial septum, with smooth and regular surfaces and clear boundaries on the left atrial view. The mass was located immediately adjacent to the aortic non-coronary sinus and the base of the anterior leaflet of the mitral valve (Panels C and D). During surgery, a dark red circular mass in the middle of the atrial septum was visualized (Panel E). The mass in the atrial septum was resected under total cardiopulmonary bypass. The post-operative course was uneventful, and the patient was discharged in a good condition 1 week after surgery. Post-operative histopathological examination revealed endothelial cells, communicating dilated vascular channels, and clusters of red blood cells inside the vascular lumen; thus, it was diagnosed as a cavernous haemangioma (Panel F).
- Open Access
- 1 January 2022
- Published by Elsevier in Cardiovascular Pathology
- Vol. 56, 107381
Cardiac fibroma: A clinicopathologic study of a series of 12 cases
- 1 January 2022
- Published by Elsevier in Cardiovascular Pathology
- Vol. 56, 107381
Open AccessCardiac fibroma: A clinicopathologic study of a series of 12 cases
- 1 March 2021
- Published by Elsevier in Cardiovascular Pathology
- Vol. 51, 107304
Isolated subclavian or brachiocephalic arteries with tetralogy of Fallot, left retro-aortic brachiocephalic vein
- 1 March 2021
- Published by Elsevier in Cardiovascular Pathology
- Vol. 51, 107304
Isolated subclavian or brachiocephalic arteries with tetralogy of Fallot, left retro-aortic brachiocephalic vein